ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 134 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2019. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $574,000 | -17.2% | 105,367 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $693,000 | -10.3% | 103,312 | +18.0% | 0.00% | 0.0% |
| Q1 2023 | $773,000 | +74.9% | 87,531 | +51.2% | 0.00% | 0.0% |
| Q4 2022 | $442,000 | -20.1% | 57,876 | -24.5% | 0.00% | 0.0% |
| Q3 2022 | $553,000 | -12.4% | 76,672 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $631,000 | -42.0% | 77,995 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $1,087,000 | -48.2% | 78,346 | +4.7% | 0.00% | -50.0% |
| Q4 2021 | $2,099,000 | -1.1% | 74,800 | +19.8% | 0.00% | 0.0% |
| Q3 2021 | $2,123,000 | -5.6% | 62,456 | +13.4% | 0.00% | 0.0% |
| Q2 2021 | $2,250,000 | +10.6% | 55,062 | +9.0% | 0.00% | -33.3% |
| Q1 2021 | $2,034,000 | -13.3% | 50,509 | +27.3% | 0.00% | 0.0% |
| Q4 2020 | $2,346,000 | +12.3% | 39,662 | -7.7% | 0.00% | -25.0% |
| Q3 2020 | $2,089,000 | -6.4% | 42,970 | -6.8% | 0.00% | 0.0% |
| Q2 2020 | $2,231,000 | +90.0% | 46,121 | +9.2% | 0.00% | +100.0% |
| Q1 2020 | $1,174,000 | +28.4% | 42,250 | +38.3% | 0.00% | +100.0% |
| Q4 2019 | $914,000 | – | 30,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |